Article Sidebar
Published:
Dec 9, 2014Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Inhibition of lipopolysaccharide-induced neuroinflammatory events in Bv-2 microglia by chestnut peel extract
Abstract
Purpose: To evaluate the protective effects of chestnut (Castenea cranata Siebold & Zucc., Fagaceae) peel extract on stimulated BV-2 microglial cells as well as its anti-oxidant properties.
Methods: The ethyl acetate fraction of C. cranata peel (CCP) extract was used in the study to evaluate the anti-neuroinflammatory effects in BV-2 microglial cells. Cell viability was performed by 3-(4, 5- dimethylthiazol-2-yl)-2, 5- diphenyl-tetrazolium bromide (MTT) assay. Lipopolysaccharide (LPS) is used to activate BV-2 microglia. Nitric oxide (NO) levels were measured using Griess assay. Inducible NO synthase (iNOS) expressional levels were measured by Western blot analysis. Tumor necrosis factoralpha (TNF-α) production was evaluated by enzyme-linked immunosorbent assay (ELISA). Anti-oxidant properties were evaluated by 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) radical scavenging assay.
Results: LPS-activated excessive release of NO in BV-2 cells was significantly inhibited (p < 0.001 at 100 μg/mL) by CCP extract. LPS-induced excessive production of inflammatory mediator such as iNOS was also significantly attenuated by CCP extract. Further, CCP extract significantly and dose dependently inhibited the TNF-α levels in LPS-induced BV-2 microglial cells (p < 0.05 at 20 μg/mL, p < 0.01 at 40 μg/mL and p < 0.001 at 80 and 100 μg/mL). CCP extract also scavenged DPPH radicals in a dose-dependent fashion (p < 0.05 at 0.01 mg/mL and p < 0.001 at 0.1 and 1 mg/mL) with an IC50 value of 0.08 μg/mL.
Conclusion: Data from this study indicate that CCP extract attenuates neuroinflammatory responses in LPS-activated BV-2 microglia by inhibiting excessive production of pro-inflammatory mediators such as NO, iNOS and TNF-α. The strong anti-oxidant effect of CCP extract suggests that it possesses antineuroinflammatory properties.
Keywords: Castenea cranata, Chestnut peel extract, DPPH radicals, Anti-oxidant, Neuroinflammation, BV-2 microglia
